Ectopic bone

Journal of Neurosurgery: Spine

Volumn 12, Issue 1, 2010, Pages 39-

  Traynelis, Vincent C ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT BONE MORPHOGENETIC PROTEIN 2;

BONE DISEASE; ECTOPIC BONE; EDEMA; HUMAN; IMPLANT; LETTER; OFF LABEL DRUG USE; RISK FACTOR; SEROMA; SPINE FUSION; TRANSFORAMINAL LUMBAR INTERBODY FUSION;

BONE MORPHOGENETIC PROTEIN 2; HUMANS; LUMBAR VERTEBRAE; OFF-LABEL USE; OSSIFICATION, HETEROTOPIC; POSTOPERATIVE COMPLICATIONS; PROSTHESIS IMPLANTATION; RECOMBINANT PROTEINS; RISK ASSESSMENT; SPINAL FUSION;

EID: 74549212661     PISSN: 15475654     EISSN: 15475646     Source Type: Journal    
DOI: 10.3171/2009.5.SPINE09338     Document Type: Letter

References (3)

1. Chen NF, Smith ZA, Stiner ES, Armin S, Sheikh H, Khoo LT: Symptomatic ectopic bone formation after off-label use of recombinant human bone morphogenetic protein-2 in transforaminal lumbar interbody fusion. Report of 4 cases. J Neurosurg Spine 12:40-46, 2009
2. Haid RW Jr, Branch CL Jr, Alexander JT, Burkus JK: Posterior lumbar interbody fusion using recombinant human bone morphogenetic protein type 2 with cylindrical interbody cages. Spine J 4:527-539, 2004
3. Wong DA, Kumar A, Jatana S, Ghiselli G, Wong K: Neurological impairment from ectopic bone in the lumbar canal: a potential complication of off-label PLIF/TLIF use of bone morphogenetic protein-2 (BMP-2). Spine J 8:1011-1018, 2008